BIONEXUS GENE LAB CORP (BGLC)
US0906282076 - Common Stock
| MRQ (2024-9-30) | 2023 (2023-12-31) | 2022 (2022-12-31) | 2021 (2021-12-31) | 2020 (2020-12-31) | ||||
|---|---|---|---|---|---|---|---|---|
| ASSETS | ||||||||
| Current Assets | ||||||||
| Cash | 2.06M | 2.62M | 610.00K | 580.00K | 700.00K | |||
| Receivables | 1.51M | 979.69K | 2.93M | 3.44M | 4.02M | |||
| Inventories | 1.39M | 1.14M | 980.00K | 1.52M | 1.18M | |||
| Other Current Assets | 2.08M | 3.31M | 1.51M | 1.61M | 2.09M | |||
| Total Current Assets | 7.04M | 8.05M | 6.02M | 7.15M | 7.99M | |||
| Non-Current Assets | ||||||||
| PPE Net | 1.96M | 1.65M | 1.57M | 1.68M | 1.85M | |||
| Investments And Advances | 1.99M | 1.70M | 1.15M | 750.00K | 280.00K | |||
| Total Non-Current Assets | 3.96M | 3.35M | 2.72M | 2.42M | 2.13M | |||
| TOTAL ASSETS | 11.00M | 11.40M | 8.74M | 9.57M | 10.12M | |||
| LIABILITIES | ||||||||
| Current Liabilities | ||||||||
| Short Term Debt | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | |||
| Current Portion Of LT Debt. | N/A | N/A | 0.00 | 20.00K | 30.00K | |||
| Accrued Expenses | 48.21K | 34.63K | 20.00K | 20.00K | 20.00K | |||
| Accounts Payable | 1.03M | 1.40M | 1.96M | 2.08M | 3.27M | |||
| Other Current Liabilities | 333.53K | 194.11K | 20.00K | 210.00K | 60.00K | |||
| Total Current Liabilities | 1.41M | 1.63M | 2.00M | 2.33M | 3.37M | |||
| Non-Current Liabilities | ||||||||
| Long Term Debt | 0.00 | 0.00 | 0.00 | 20.00K | 40.00K | |||
| Deferred Taxes/Income | 13.65K | 12.26K | 30.00K | 30.00K | 0.00 | |||
| Other Non-Current Liabilities | 178.37K | 98.76K | 40.00K | 10.00K | 40.00K | |||
| Total Non-Current Liabilities | 192.01K | 111.02K | 80.00K | 60.00K | 80.00K | |||
| TOTAL LIABILITIES | 1.61M | 1.74M | 2.08M | 2.39M | 3.45M | |||
| SHAREHOLDERS' EQUITY | ||||||||
| Retained Earnings | -3.09M | -1.84M | 1.16M | 1.51M | 760.00K | |||
| Additional Paid In Capital | -5.01M | -5.01M | -5.01M | -5.01M | -5.01M | |||
| Common Shares | 17.33M | 17.19M | 10.93M | 10.78M | 10.78M | |||
| Other Shareholders' Equity | 162.05K | -677.29K | -410.00K | -100.00K | 130.00K | |||
| Shares Outstanding | 17.97M | 17.67M | 14.48M | 14.27M | 14.27M | |||
| Tangible Book Value per Share | 0.52 | 0.55 | 0.46 | 0.50 | 0.47 | |||
| Total Shareholders' Equity | 9.39M | 9.66M | 6.67M | 7.18M | 6.66M | |||
| TOTAL LIABILITIES AND EQUITY | 11.00M | 11.40M | 8.74M | 9.57M | 10.12M | |||
| Statistics | ||||||||
| Debt/Equity | N/A | N/A | N/A | 0.00 | 0.01 | |||
| Current Ratio | 4.98 | 4.93 | 3.01 | 3.07 | 2.37 | |||
| Return On Assets (ROA) | -8.57% | -23.06% | -4.12% | 7.84% | 10.77% | |||
| Return On Equity (ROE) | -10.04% | -27.22% | -5.40% | 10.45% | 16.37% | |||
| Return On Invested Capital (ROIC) | N/A | N/A | N/A | 11.46% | 14.86% | |||
| Return On Invested Capital Ex Cash (ROICexc) | N/A | N/A | N/A | 11.46% | 14.86% | |||
| Return On Invested Capital Ex Cash + Goodwill (ROICexcg) | N/A | N/A | N/A | 11.46% | 14.86% | |||
All data in USD , ROIC based on taxRate of 0.21